Skip to main content

Table 4 Hazard ratio (HR) of different types of CVD in BC patients after chemotherapy

From: Cardiovascular disease in women with breast cancer – a nationwide cohort study

  Hypertension Cerebrovascular disease Ischemic heart disease/ACSa Atrial fibrillation Heart failure Thrombophlebitis/thrombosis Pulmonary heart disease Peripheral vascular disease Heart valve disease Other cardiac arrhythmias
Chemotherapy 0.849 1.012 1.004 1.189 1.738** 1.737** 1.408 0.962 1.014 1.130
Number of observations, N 15,574 16,000 15,874 16,080 16,245 16,387 16,453 16,411 16,388 16,396
  1. The following covariates were included in the model: Age, region of residence, education, cohort (year of diagnosis), distant metastasis when diagnosed with BC and comorbidity at index date (CCI, diabetes or CVD (CVD at index date was defined by CVD drug prescriptions in NPDR
  2. * p < 0.05, ** p < 0.01, *** p < 0.001
  3. aACS = Acute Cornoary Syndrome